A Bloomberg dollar index was steady while the yield on 10-year US Treasury yields advanced two basis points. Oil and gold ...

April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ... The redemption price will be payable in cash and equal to 100% of the principal amount of each Note called ...

We'll use ROE to examine Collegium Pharmaceutical, Inc. (NASDAQ:COLL), by way of a worked example. ROE or return on equity is a useful tool to assess how effectively a company can generate returns ...

which is in a Phase I clinical trial in patients with select advanced solid tumors. The company was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012.

Biostar Pharmaceuticals, Inc. develops, manufactures ... compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever ...

Counsel have not yet appeared for the defendant. The case is 3:24-cv-04607, Salix Pharmaceuticals, Inc. v. Amneal Pharmaceuticals Of New York, LLC.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Counsel have not yet appeared for the defendants. The case is 1:24-cv-04607, Salix Pharmaceuticals, Inc. v. Amneal Pharmaceuticals Of New York, LLC.

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Goldman Sachs and Leerink Partners are acting as lead joint book-running managers for the proposed offering. Evercore ISI, Guggenheim Securities and BMO Capital Markets are also acting as joint ...